News | February 04, 2015

Repeating ultrasound after chemotherapy helps determine which lymph nodes should be removed and tested

Mayo Clinic, breast cancer, ultrasound, lymph nodes, women's health, study

February 4, 2015 — A new Mayo Clinic study finds that not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all of their underarm nodes taken out. Ultrasound is a useful tool for judging before breast cancer surgery whether chemotherapy eliminated cancer from the underarm lymph nodes, the researchers found. The findings are published in the Journal of Clinical Oncology.

In the past, when breast cancer was discovered to have spread to the lymph nodes under the arm, surgeons routinely removed all of them. Taking out all of those lymph nodes may cause arm swelling called lymphedema and limit the arm's range of motion.

Now, many breast cancer patients receive chemotherapy before surgery. Thanks to improvements in chemotherapy drugs and use of targeted therapy, surgeons are seeing more women whose cancer is eradicated from the lymph nodes by the time they reach the operating room, said lead author Judy C. Boughey, M.D., a breast surgeon at Mayo Clinic in Rochester.

The current study finds that repeating ultrasound after chemotherapy is a sound way to help determine whether surgeons should remove only a few lymph nodes and test them for cancer, sparing patients whose sentinel nodes are cancer-free the removal of all nodes in the armpit, or take out all of the nodes, Boughey said.

"Our goal here is really to try to get away from, 'Every patient with breast cancer needs these drugs, and this amount of chemotherapy and this surgery,' and instead to personalize surgical treatment based on how the patient responds to chemotherapy," Boughey said.

Avoiding complete underarm lymph node removal when possible means fewer women will experience the complications that can accompany that surgery, and avoiding those side effects should also save health care costs, she says.

"That's one of the really nice things about giving chemotherapy up front: It allows us to be less invasive with surgery, both in terms of breast surgery and lymph node surgery, and to tailor treatment based on response to chemotherapy," Boughey said.

Most patients with lymph node-positive breast cancer receive radiation treatment after surgery. A new study is under way for men and women with breast cancer whose underarm lymph nodes are still positive for cancer after chemotherapy. It will evaluate which is more effective: removing all of those nodes, or leaving the nodes and treating them with radiation, Boughey said.

For more information: www.mayoclinic.org


Related Content

News | Ultrasound Women's Health

May 25, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), deep ...

Time May 25, 2023
arrow
News | Radiation Oncology

May 22, 2023 — Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest ...

Time May 22, 2023
arrow
News | Mammography

May 22, 2023 — Incorrect advice by an AI-based decision support system could seriously impair the performance of ...

Time May 22, 2023
arrow
News | Breast Imaging

May 16, 2023 — DenseBreast-info.org has issued a statement which states that the USPSTF Guideline should not apply to ...

Time May 16, 2023
arrow
News | Breast Imaging

May 15, 2023 — RSNA updated its Statement on Screening for Breast Cancer, recognizing new recommendations from the ...

Time May 15, 2023
arrow
News | Breast Imaging

May 12, 2023 — The new United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations are ...

Time May 12, 2023
arrow
News | Breast Imaging

May 11, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time May 11, 2023
arrow
News | Mammography

May 11, 2023 — The Radiological Society of North America (RSNA) has announced the results of the RSNA Screening ...

Time May 11, 2023
arrow
News | Breast Imaging

May 10, 2023 — Hologic has issued a statement in reaction to the proposed USPSTF guidelines. As a leader in women’s ...

Time May 10, 2023
arrow
Feature | Breast Imaging

May 9, 2023 — The U.S. Preventive Services Task Force (Task Force) today posted a draft recommendation statement on ...

Time May 09, 2023
arrow
Subscribe Now